Through its subsidiary - Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals announced that through its 100% owned subsidiary, Alembic Pharmaceuticals Inc. , it has completed the acquisition of West Caldwell, New Jersey, USA based generic drug developer Orit Laboratories LLC along with real estate, owned by Okner Realty LLC.Orit is focused on developing and filing oral solid and liquid products. Orit has seven approved ANDAs and four ANDAs pending approval.
With this acquisition, Alembic will now have a total of 69 ANDA approvals (61 final and 8 tentative) from USFDA.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)